EyePoint (EYPT) Retained Earnings (2011 - 2026)
EyePoint (EYPT) reported Retained Earnings of -$1.2 billion for Q1 2026, down 29.58% on a YoY basis from -$1.7 billion in Q1 2025, and down 7.68% sequentially from -$1.1 billion in Q4 2025.
EyePoint (EYPT) Retained Earnings (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 16 years of Retained Earnings data on file, last reported at -$1.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 29.58% year-over-year to -$1.2 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.2 billion (down 29.58% YoY), and the FY2025 full-year result was -$1.1 billion, down 107588.13% from the prior year.
- Retained Earnings slipped to -$1.2 billion in Q1 2026, from -$1.1 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.2 million in Q3 2024 to a low of -$1.2 billion in Q1 2026.
- A 5-year average of -$538.5 million and a median of -$692.5 million in 2023 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings tumbled 111592.65% in 2023 and jumped 100.16% in 2024, its largest moves.
- Tracing EYPT's Retained Earnings over 5 years: stood at $786000.0 in 2022, then gained by 9.92% to $864000.0 in 2023, then gained by 18.98% to $1.0 million in 2024, then sank by 107588.13% to -$1.1 billion in 2025, then fell by 7.68% to -$1.2 billion in 2026.
- Business Quant data shows EYPT's Retained Earnings at -$1.2 billion in Q1 2026, -$1.1 billion in Q4 2025, and -$1.0 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | -1.19 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.19 Bn |
| Dec 31, 2025 | -1.10 Bn |
| Sep 30, 2025 | -1.04 Bn |
| Jun 30, 2025 | 832,000.00 |
| Mar 31, 2025 | -918.21 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | -802.26 Mn |
| Mar 31, 2024 | -771.43 Mn |
| Dec 31, 2023 | 864,000.00 |
| Sep 30, 2023 | -728.05 Mn |
| Jun 30, 2023 | -715.44 Mn |
| Mar 31, 2023 | -692.52 Mn |
| Dec 31, 2022 | 786,000.00 |
| Sep 30, 2022 | 653,000.00 |
| Jun 30, 2022 | -609.48 Mn |
| Mar 31, 2022 | -590.07 Mn |
| Dec 31, 2021 | -569.10 Mn |
| Sep 30, 2021 | 841,000.00 |
| Jun 30, 2021 | 841,000.00 |